Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Acta Gastroenterol Belg ; 83(4): 517-525, 2020.
Article in English | MEDLINE | ID: mdl-33321006

ABSTRACT

BACKGROUND AND STUDY AIMS: The Coronavirus Disease 2019 (COVID-19) epidemic especially worries people with chronic diseases the entire world. In this study, the frequency, and clinical course of COVID-19 infection in patients with Celiac disease (CD) were investigated. CD patients' adherence to purchasing gluten free products (GFPs), the strict diet, and how patients' anxiety affects CD symptoms during the COVID-19 outbreak were also examined. PATIENTS AND METHODS: A detailed questionnaire was administered by telephone and emailed to the CD patients to determine the status of these patients in obtaining GFPs, and dietary compliance during the COVID-19 pandemic. State and trait anxiety levels of patients were evaluated using the State-trait Anxiety Inventory (STAI) scale. Additionally, whether patients with CD were diagnosed with COVID-19, and if diagnosed, their clinical course of the disease were investigated. RESULTS: One hundred and one patients were included in the study. The total number of patients who could obtain GFPs decreased significantly in the pandemic than before the pandemic. The patients' state anxiety index was 40.7±7.9, and the trait anxiety index was 44.5±8.5, and all patients were evaluated as mildly anxious. During the pandemic, two female patients were diagnosed with COVID-19. CONCLUSION: CD patients did not have any additional risk compared to other individuals in terms of becoming infected with COVID-19 for patients under gluten free diet, and these patients will have a similar clinical course as individuals without CD.


Subject(s)
COVID-19 , Celiac Disease , Anxiety/epidemiology , Anxiety/etiology , Celiac Disease/diagnosis , Celiac Disease/epidemiology , Diet, Gluten-Free , Female , Humans , Pandemics , SARS-CoV-2
2.
Acta Gastroenterol Belg ; 83(2): 249-254, 2020.
Article in English | MEDLINE | ID: mdl-32603043

ABSTRACT

INTRODUCTION: We studied the relation between premalignant gastric lesions and cyclooxygenase-2 (COX-2) expression. METHODS: The study included 254 patients, who were histo- logically diagnosed with chronic active gastritis, atrophy, dys- plasia and metaplasia. Gastric biopsy specimens of the patients were histopathologically examined in terms of the presence of Helicobacter pylori (H. pylori) infection, atrophy The Operative Link for Gastritis Assessment ; (OLGA staging system), dysplasia (Vienna classification), and metaplasia (Sydney classification). COX-2 expression was investigated by immunohistochemical staining. COX-2 immunoreactivity score was calculated as the product of staining intensity and staining area. A score of >1 was defined as COX-2-positive expression. RESULTS: Of these patients, 84 (33.1%) had negative COX-2 expression (Score 0 and Score 1) and 170 (66.9%) had positive COX2 expression (Score 2 and Score 3). We found that in patients with a moderate-marked metaplasia, or with moderate-severe atrophy, a higher OLGA stage, or with dysplasia, the COX-2 expression was found to be higher than those with mild lesions. In 59.8% of the patients H. pylori was positive. While, the rate of severe atrophy was higher in H. pylori-positive patients ; no significant difference was determined between the H. pylori-positive and H. pylori-negative patients regarding age, smoking status, intestinal metaplasia grade, dysplasia, and COX-2 expression. CONCLUSION: We found a relation between the level of COX-2 expression and the grade of premalignant gastric lesions. COX-2 plays an important role in the gradual process resulting eventually in gastric cancer.


Subject(s)
Cyclooxygenase 2 , Gastritis , Helicobacter Infections , Helicobacter pylori , Stomach Neoplasms , Cyclooxygenase 2/metabolism , Gastric Mucosa , Humans , Metaplasia , Stomach Neoplasms/metabolism
3.
Bratisl Lek Listy ; 117(12): 722-725, 2016.
Article in English | MEDLINE | ID: mdl-28127969

ABSTRACT

BACKGROUND AND AIM: Acute hind limb ischemia reperfusion (I/R) injury is a common consequence of abdominal aorta cross­clamping during aortic surgery. Erythrocyte deformability is affected by I/R process and may lead to increased tissue and organ injury. Lornoxicam and intravenous ibuprofen are becoming commonly used as non-steroidal anti-inflammatory drugs (NSAID) for postoperative analgesia. In this study, we aimed to investigate the effects of lornoxicam (2 mg/kg iv) and intravenous ibuprofen (30 mg/kg iv) on erythrocyte deformability in I/R model in rats. MATERIALS AND METHODS: Four study groups, each containing 6 Wistar rats were created. Laparotomy was performed in all groups under general anesthesia with ketamine and xylazine. In all groups except sham group, ischemia and reperfusion were achieved by clamping and declamping the infrarenal abdominal aorta for 120 minutes. Rats in Group IR+L received intravenous infusion of lornoxicam (2 mg/kg) while rats in Group IR+I received intravenous infusion of ibubrofen (30 mg/kg) following 2 hours of ischemic period. At the end of reperfusion period, erythrocyte packs were prepared from heparinized blood samples. Erythrocyte suspensions with hematocrit at a concentration of 5% in a phosphate­buffered saline (PBS) were used in order to perform deformability measurements. The value of p<0.05 was considered statistically significant. RESULTS: Relative resistance has increased in ischemia reperfusion group when compared to control group (p < 0.0001). Lornoxicam or ibuprofen intravenous treatments did not change the erythrocyte deformability during ischemia reperfusion period in rats (p=0.851, p=0.690). CONCLUSION: Intravenous ibuprofen or lornoxicam administrations during ischemia reperfusion period in rats have no negative effect on erythrocyte deformability. The findings of the study should be supported with more detailed and extensive clinical/experimental studies in the future (Fig. 1, Ref. 18).


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Erythrocyte Deformability/drug effects , Ibuprofen/administration & dosage , Piroxicam/analogs & derivatives , Reperfusion Injury/drug therapy , Administration, Intravenous , Analgesia/methods , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Erythrocytes , Hindlimb/blood supply , Ibuprofen/pharmacology , Infusions, Intravenous , Ischemia/drug therapy , Male , Pain, Postoperative , Piroxicam/administration & dosage , Piroxicam/pharmacology , Rats , Rats, Wistar
4.
J Hosp Infect ; 85(3): 226-9, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24001998

ABSTRACT

An increase in the number of cases of postoperative empyema due to S. marcescens was recognized in the intensive care unit (ICU) of our Division of Thoracic Surgery between 3 and 19 March 2013. Pleural samples from patients and environmental samples from the operating room and ICU were obtained. A total of eight isolates (six from pleural fluid and two from portable suction devices in ICU) were identified as Serratia marcescens. All isolates were found to be identical by repetitive sequence-based polymerase chain reaction. This is the first report of an outbreak caused by S. marcescens related to a contaminated portable suction machine.


Subject(s)
Disease Outbreaks , Empyema, Pleural/epidemiology , Serratia Infections/epidemiology , Serratia marcescens/isolation & purification , Surgical Wound Infection/epidemiology , Adult , Empyema, Pleural/microbiology , Environmental Microbiology , Genotype , Humans , Intensive Care Units , Male , Middle Aged , Molecular Epidemiology , Molecular Typing , Polymerase Chain Reaction , Serratia Infections/microbiology , Surgical Wound Infection/microbiology , Thoracic Surgery
5.
Nufusbil Derg ; 20: 43-56, 1998.
Article in Turkish | MEDLINE | ID: mdl-12349074

ABSTRACT

PIP: "The main objective of the study is to answer the question... How does [the] decision-making process in marriage formation work in Turkey? Data used in the study come from the 1993 Turkish Demographic and Health Survey.... Educational level of women...has [a] much more powerful effect on [the] decision-making process in marriage formation than the educational level of husbands. The role of women in the process of marriage formation increases as the educational level of women increases." (EXCERPT)^ieng


Subject(s)
Decision Making , Educational Status , Marital Status , Marriage , Women's Rights , Asia , Asia, Western , Behavior , Developing Countries , Economics , Social Behavior , Social Class , Socioeconomic Factors , Turkey
6.
Intensive Care Med ; 22(6): 519-29, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8814466

ABSTRACT

OBJECTIVE: To determine possible changes in outcome from acute respiratory distress syndrome (ARDS) and to compare severity of lung injury and methods of treatment from 1967 to 1994. DATA SOURCES: Computerized (Medline, Current Contents) and manual (Cumulated Index Medicus) literature search using the key word and/or title ARDS. STUDY SELECTION: Only clinical studies published as full papers reporting data on both patient mortality (survival) and oxygenation index (PaO2/FIO2) were included. Single case reports, abstracts, reviews and editorials were excluded from evaluation. DATA EXTRACTION: Relevant data were extracted in duplicate, followed by quality checks on approximately 80% of data extracted. DATA SYNTHESIS: 101 papers reporting on 3264 patients were included: 48 studies (2207 patients) were performed in the USA, 43 studies (742 patients) in Europe and 10 studies (315 patients) elsewhere. Mortality reported in these studies was 53 +/- 22% (mean +/- SD), with no apparent trend towards a higher survival (1994: 22 studies, mortality 51 +/- 19%). The mean PaO2/FIO2 ratio remained unchanged throughout the observation period (118 +/- 47 mmHg). No correlation could be established between outcome and PaO2/FIO2 or lung injury score. Patients who underwent pressure-limited ventilation had a significantly lower mortality (35 +/- 20%) than patients on volume-cycled ventilation (54 +/- 22%) or patients for whom there was no precise information on ventilatory support (59 +/- 19%). Significantly lower PaO2/FIO2 ratios (61 +/- 17 mmHg) were observed in patients prior to extracorporeal lung assist, together with mortality rates in the range of those for conventionally treated patients (55 +/- 22%). CONCLUSIONS: The mortality of ARDS patients remained constant throughout the period studied. Therefore, the standard for outcome in ARDS should be a mortality in the 50% range. Neither PaO2/FIO2 ratio nor lung injury score was a reliable predictor for outcome in ARDS. Patients might benefit from pressure-limited ventilatory support, as well as extracorporeal lung assist. Since crucial data were missing in most clinical studies, thus preventing direct comparison, we emphasize the importance of using standardized definitions and study entry criteria.


Subject(s)
Respiratory Distress Syndrome/classification , Respiratory Distress Syndrome/mortality , APACHE , Analysis of Variance , Humans , Mortality/trends , Oxygen/blood , Patient Selection , Respiration, Artificial/methods , Respiratory Distress Syndrome/therapy , Severity of Illness Index , Statistics, Nonparametric , Treatment Outcome
7.
Chest ; 109(2): 486-93, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8620727

ABSTRACT

STUDY OBJECTIVE: To evaluate the percentage of nitric oxide (NO) responders in septic shock patients with ARDS. Additionally, to investigate long-term NO effects on cardiac performance and oxygen kinetic patterns in NO responders vs nonresponders. DESIGN: Prospective cohort study. SETTING: ICU of a university hospital. PATIENTS: Twenty-five consecutive patients with a diagnosis of septic shock and established ARDS requiring inotropic and vasopressor support. INTERVENTIONS: After diagnosis of ARDS, NO was administered at 18 or 36 ppm. Patients demonstrating a NO-induced rise of arterial oxygen tension of 20% or more and/or a fall in mean pulmonary artery pressure of 15% or more were grouped as NO responders; others were grouped as nonresponders. MEASUREMENTS AND RESULTS: Ten patients (40%) were NO responders, while 15 patients (60%) were nonresponders. Mortality was 40% in NO responders and 67% in nonresponders (NS). NO responders developed a significantly lower mean pulmonary artery pressure (28 +/- 6 vs 33 +/- 6 mm Hg; p < 0.05), lower pulmonary vascular resistance (PVR: 258 +/- 73 vs 377 +/- 163 dyne.s.cm-5.m-2; p < 0.05), and higher PaO2/FIO2 ratio (192 +/- 85 vs 144 +/- 74 mm Hg; p < 0.05) within the study period. In responders, NO-induced afterload reduction resulted in increased right ventricular ejection fraction (RVEF: 40 +/- 7 vs 35 +/- 9%; p < 0.05), significantly higher cardiac index (CI: 4.5 +/- 1.1 vs 4.0 +/- 1.2 L.min-1.m-2; p < 0.05) and oxygen delivery (DO2: 681 +/- 141 vs 599 +/- 160 mL.min-1.m-2; p < 0.05) compared with nonresponders. In NO nonresponders, RVEF was correlated with PVR, CI, DO2, mixed venous oxygen saturation (SvO2), and oxygen extraction ratio (O2ER) (r = +/- 0.60 to +/- 0.69; p < 0.05). No significant correlation between RVEF and any of these parameters was observed in responders. SvO2 (75 +/- 7 vs 69 +/- 8%; p < 0.05) and O2ER (0.24 +/- 0.06 vs 0.27 +/- 0.06; p < 0.05) were significantly different between responders and nonresponders, while no difference in oxygen consumption was observed (161 +/- 41 vs 153 +/- 43 mL.min.m-2). CONCLUSIONS: Inhaled NO is effective in only a subgroup of septic ARDS patients, with a higher, but insignificantly different percentage of survivors in the responder group. NO responders were characterized by increased RVEF accompanied by higher CI, DO2, and lower O2ER. In nonresponders, RVEF remained depressed, with a close correlation between RVEF and CO as well as DO2 and O2ER. Thus, nonresponders seem to suffer from impaired cardiac reserves and correspondingly lower oxygen transport variables.


Subject(s)
Nitric Oxide/therapeutic use , Respiratory Distress Syndrome/complications , Respiratory Distress Syndrome/drug therapy , Shock, Septic/complications , Administration, Inhalation , Adult , Aged , Hemodynamics , Humans , Middle Aged , Prospective Studies , Respiratory Distress Syndrome/physiopathology , Shock, Septic/physiopathology , Stroke Volume , Treatment Outcome , Ventricular Function, Right
8.
Article in English | MEDLINE | ID: mdl-8599283

ABSTRACT

Mild hypothermia (33 degrees C to 35.5 degrees C) is reported to improve oxygenation and survival in patients with lung failure (1). Although hypermetabolism may account for about 50% of the ventilatory demand in ARDS patients, the concept of reducing oxygen consumption (VO2) by lowering metabolic rate, has only recently gained attention (2). Our study was aimed to test whether mild hypothermia established by continuous veno-venous haemofiltration (CVVHF), could optimize values for oxygen kinetics in ARDS patients. Overall, we recruited 27 patients with ARDS and sepsis. Prior initiation of CVVHF patients had to meet the following criteria: a) Murray score > 2.5, and hypoxaemia with PaO2/FIO2 < 200, b) hyperthermia of > 38 degrees C, c) cardiovascular instability requiring inotropic support. Evaluation of cardio-respiratory data was performed within four different phases (I = before, II + III during and IV = after CVVHF) every 6 hours. Core temperature as derived from the thermistor of pulmonary artery catheter was aimed to be between 35.0 degrees C and 36.5 degrees C. Optimal values for oxygen delivery (DO2) (> 550 mL/min/m2) and VO2 (> 160 mL/min/m2) were defined according to Shoemaker and achieved by fluid loading, transfusion and inotropic support (3). Septic shock occurred in 10 of 14 nonsurvivors (nons) and 2 of 13 survivors (surv). Mean values for DO2 and VO2 were calculated at different body temperature ranges. While at 37 degrees C DO2 was identical between surv and nons, (663 +/- 128 versus 666 +/- 127 means +/- SD) moderate hypothermia led to a small decrease of DO2 in surv and a significant decrease in nons (632 +/- 134 versus 605 +/- 128 mL/min/m2) at 35 degrees C. Concerning VO2 during hypothermia, there was a significant drop in nonsurvivors while in survivors the decrease was less pronounced. We could demonstrate a decrease in DO2 and VO2 during mild hypothermia during CVVHF. However, decreases in nonsurvivors were more pronounced than in survivors. These results suggest that the inability to achieve optimal values for DO2 and VO2 during mild hypothermia induced by CVVHF could serve as a prognostic sign for fatal outcome. Although oxygen consumption is decreased during hypothermia, hypoxaemia may result due to alterations of the oxygen transport on a cellular basis. The relationship between oxygen transport and temperature during CVVHF therefore deserves further studies.


Subject(s)
Bacterial Infections/blood , Hypothermia, Induced , Oxygen/blood , Respiratory Distress Syndrome/blood , Adolescent , Adult , Aged , Bacterial Infections/therapy , Blood Transfusion , Body Temperature , Cardiac Output, Low/blood , Cardiac Output, Low/drug therapy , Cardiac Output, Low/therapy , Cardiotonic Agents/therapeutic use , Female , Fever/blood , Fluid Therapy , Hemofiltration , Humans , Hypoxia/blood , Male , Middle Aged , Oxygen Consumption , Prognosis , Respiratory Distress Syndrome/therapy , Shock, Septic/etiology , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...